Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer
Clinical trial NCT00773773 · TERMINATED
Trial details
- NCT number
- NCT00773773
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-14
- Primary completion
- 2024-03-08
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.